Skip to content
Screener

Total Assets at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$2.99B+0.3%
ALN
Alnylam PharmaceuticalsALNY
$5.56B+21.7%
Assembly Biosciences logo
Assembly BiosciencesASMB
$235.51M+138%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$277.16M+137%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$1.26B-3.2%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$1.48B+0.9%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemMarch 31, 2026September 30, 2025
Intangible assets, net6,0116,861
Right-of-use assets42,79443,891
Other assets4,8871,389
Total Assets$2,268,265$1,385,295
LIABILITIES, NONCONTROLLING INTEREST AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable30,747$17,674
Accrued expenses76,58590,419

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's total assets?
Arrowhead Research (ARWR) reported total assets of $2.27B in Q1 2026.
How has Arrowhead Research's total assets changed year-over-year?
Arrowhead Research's total assets increased by 44.2% year-over-year, from $1.57B to $2.27B.
What is the long-term trend for Arrowhead Research's total assets?
Over 4 years (2021 to 2025), Arrowhead Research's total assets has grown at a 18.2% compound annual growth rate (CAGR), from $710.15M to $1.39B.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Ask your AI about Arrowhead Research's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude